Skip to content

Aaris Acrylic Intraocular lens(IOL) EC-3 PAL (REF fEC-3 PAL/9)Recalls & reported problems

Aaren Scientific Inc. · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00884872025732), received between Aug 13, 2020 and Aug 13, 2020 — classified as 1 injury.

The most frequently reported specific device problem is “Device Handling Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Device Handling Problem1
  • Material Integrity Problem1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 13, 2020Material Integrity Problem; Device Handling Problem; Material Integrity Problem; Device Handling Problem

    IT WAS REPORTED THAT DURING THE ATTEMPT TO IMPLANT THE LENS THE HAPTIC INSERTED AT A DIFFERENT ANGLE THAN THE OTHER ONE THUS THE LENS WAS REMOVED. AFTER INSERTING THE SPARE LENS IT WAS NOTED THAT THE HAPTIC WAS BROKEN. THUS, THIS LENS AS WELL WAS REMOVED. A THIRD LENS WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. NO ADVERSE PATIENT EFFECTS OR CLINICALLY SIGNIFICANT DELAY IN PROCEDURE REPORTED. NO ADDITIONAL INFORMATION PROVIDED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10405137 ↗

Other Intraocular Lens devices

All Intraocular Lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page